Rhythm Pharmaceuticals Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Rhythm Pharmaceuticals Inc had 62.14M in cash and cash equivalents.

Rhythm Pharmaceuticals Inc reported 210.17M in total liabilities as of the latest reported quarter, including 105.94M in current liabilities and 104.23M in non-current liabilities.

As of the latest reported quarter, Rhythm Pharmaceuticals Inc's total assets were 480.20M, consisting of 466.92M in current assets and 13.28M in non-current assets.

Rhythm Pharmaceuticals Inc reported 270.03M in total shareholders' equity as of the latest reported quarter.